Submitted:
12 November 2025
Posted:
13 November 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Preparation of Sarkosyl–Insoluble Fractions from Mice’ Brains
2.1.1. Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
2.1.2. Western Blot
2.2. Preparation of Primary Neuronal Cultures from Embryonic Cortical Mice
2.2.1. Emulation of Thaopaties In Vitro I: Sarkosyl Insoluble Fraction of P301S Mice
- Standard culture (Std): Neurons developed following the standard laboratory protocol. These measurements provided a reference for normal network development and activity that could be compared with treated cultures.
- Wild–type extracellular tau (WT): Medium containing P301S (-/-) insoluble-sarkosyl fraction, which was hypothesized to be innocuous, was administered to the cultures.
- Pathological extracellular tau (pTau): Medium containing potentially harmful hyperphosphorilated tau, derived from P301S (+/-) insoluble-sarkosyl fraction, was administered to the cultures.
2.2.2. Emulation of Thaopaties in vitro II: P301L Mutated Tau Delivered Through AAVs
- Standard culture (Std): Neurons developed following the standard laboratory protocol.
- Viral P301L condition (vStd): Cells were infected at DIV 1 with AAV-P301L to induce expression of P301L-mutated tau. From this time point onwards, cultures were manipulated as in standard conditions.
- Viral P301L + wild–type tau (vWT): Cells were infected with the AAV-P301L at DIV 1. At DIV 5, P301S (-/-) insoluble sarkosyl fraction was included.
- Viral P301L + pTau (vpTau): Cells were infected with the AAV-P301L at DIV 1. At DIV 5 P301S (+/-) insoluble sarkosyl fraction (pTau) was included.
2.3. Data Acquisition and Analysis
2.3.1. Calcium Fluorescence Imaging
2.3.2. Data Analysis and Event Detection
2.3.3. Networks Dynamical Characteristics
2.3.4. Effective Connectivity Analysis and Network Measures
3. Results
3.1. Sarkosyl-Insoluble Fractions from P301S Mice’ Brains Contain Phospho-Tau and Tau Filaments
3.2. Cortical Neurons in Culture Express P301L Human Tau
3.3. Activity and Connectivity in Neuronal Cultures Treated with P301S Sarkosyl–Insoluble Fraction
3.3.1. P301S (+/-) Sarkosyl–Insoluble Fraction Does Not Alter Networks Dynamics
3.3.2. Presence of P301S Extracellular Pathological pTau Does Not Alter Effective Connectivity
3.4. Accentuation of Damage in Culture by Incorporating the P301L Mutation
3.4.1. Neuronal Cultures Expressing P301L Human Tau Exhibit a Tendency Toward Stronger Bursting
3.4.2. Cultures with Expression of P301L Human Tau Do Not Alter Effective Connectivity
4. Discussion
4.1. Network Behavior
4.2. Comparison with Other Models
4.3. A Possible Hyperexcited State Due to pTau?
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wang, Y.; Mandelkow, E. Tau in physiology and pathology. Nature reviews neuroscience 2016, 17, 22–35. [Google Scholar] [CrossRef]
- Guo, T.; Noble, W.; Hanger, D.P. Roles of tau protein in health and disease. Acta neuropathologica 2017, 133, 665–704. [Google Scholar] [CrossRef]
- Zhang, J.; Zhang, Y.; Wang, J.; Xia, Y.; Zhang, J.; Chen, L. Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies. Signal transduction and targeted therapy 2024, 9, 211. [Google Scholar] [CrossRef]
- Grossman, M.; Seeley, W.W.; Boxer, A.L.; Hillis, A.E.; Knopman, D.S.; Ljubenov, P.A.; Miller, B.; Piguet, O.; Rademakers, R.; Whitwell, J.L.; et al. Frontotemporal lobar degeneration. Nature Reviews Disease Primers 2023, 9, 40. [Google Scholar] [CrossRef]
- Lee, V.M.; Goedert, M.; Trojanowski, J.Q. Neurodegenerative tauopathies. Annual review of neuroscience 2001, 24, 1121–1159. [Google Scholar] [CrossRef] [PubMed]
- Moore, K.B.; Hung, T.J.; Fortin, J.S. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer’s disease and related tauopathies. Drug discovery today 2023, 28, 103487. [Google Scholar] [CrossRef] [PubMed]
- Götz, J.; Halliday, G.; Nisbet, R.M. Molecular pathogenesis of the tauopathies. Annual Review of Pathology: Mechanisms of Disease 2019, 14, 239–261. [Google Scholar] [CrossRef]
- Gómez-Ramos, A.; Díaz-Hernández, M.; Rubio, A.; Miras-Portugal, M.T.; Avila, J. Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Molecular and Cellular Neuroscience 2008, 37, 673–681. [Google Scholar] [CrossRef]
- Bouillet, T.; Ciba, M.; Alves, C.L.; Rodrigues, F.A.; Thielemann, C.; Colin, M.; Buée, L.; Halliez, S. Revisiting the involvement of tau in complex neural network remodeling: analysis of the extracellular neuronal activity in organotypic brain slice co-cultures. Journal of Neural Engineering 2022, 19, 066026. [Google Scholar] [CrossRef] [PubMed]
- Esteras, N.; Abramov, A.Y. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells 2020, 9, 2135. [Google Scholar] [CrossRef]
- David, D.C.; Hauptmann, S.; Scherping, I.; Schuessel, K.; Keil, U.; Rizzu, P.; Ravid, R.; Dröse, S.; Brandt, U.; Müller, W.E.; et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. Journal of Biological Chemistry 2005, 280, 23802–23814. [Google Scholar] [CrossRef] [PubMed]
- Dickerson, B.; Salat, D.; Greve, D.; Chua, E.; Rand-Giovannetti, E.; Rentz, D.; Bertram, L.; Mullin, K.; Tanzi, R.; Blacker, D.; et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005, 65, 404–411. [Google Scholar] [CrossRef]
- Palop, J.J.; Mucke, L. Synaptic depression and aberrant excitatory network activity in Alzheimer’s disease: two faces of the same coin? Neuromolecular medicine 2010, 12, 48–55. [Google Scholar] [CrossRef]
- Pooler, A.M.; Phillips, E.C.; Lau, D.H.; Noble, W.; Hanger, D.P. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO reports 2013, 14, 389–394. [Google Scholar] [CrossRef]
- Sanders, D.W.; Kaufman, S.K.; DeVos, S.L.; Sharma, A.M.; Mirbaha, H.; Li, A.; Barker, S.J.; Foley, A.C.; Thorpe, J.R.; Serpell, L.C.; et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82, 1271–1288. [Google Scholar] [CrossRef]
- Clavaguera, F.; Bolmont, T.; Crowther, R.A.; Abramowski, D.; Frank, S.; Probst, A.; Fraser, G.; Stalder, A.K.; Beibel, M.; Staufenbiel, M.; et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nature cell biology 2009, 11, 909–913. [Google Scholar] [CrossRef]
- Frost, B.; Diamond, M.I. Prion-like mechanisms in neurodegenerative diseases. Nature Reviews Neuroscience 2010, 11, 155–159. [Google Scholar] [CrossRef] [PubMed]
- Audouard, E.; Houben, S.; Masaracchia, C.; Yilmaz, Z.; Suain, V.; Authelet, M.; De Decker, R.; Buée, L.; Boom, A.; Leroy, K.; et al. High–molecular-weight paired helical filaments from Alzheimer brain induces seeding of wild-type mouse tau into an Argyrophilic 4R tau pathology in vivo. The American journal of pathology 2016, 186, 2709–2722. [Google Scholar] [CrossRef]
- Guo, J.L.; Narasimhan, S.; Changolkar, L.; He, Z.; Stieber, A.; Zhang, B.; Gathagan, R.J.; Iba, M.; McBride, J.D.; Trojanowski, J.Q.; et al. Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice. Journal of Experimental Medicine 2016, 213, 2635–2654. [Google Scholar] [CrossRef] [PubMed]
- Lasagna-Reeves, C.A.; Castillo-Carranza, D.L.; Sengupta, U.; Guerrero-Munoz, M.J.; Kiritoshi, T.; Neugebauer, V.; Jackson, G.R.; Kayed, R. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Scientific reports 2012, 2, 700. [Google Scholar] [CrossRef]
- Clavaguera, F.; Hench, J.; Goedert, M.; Tolnay, M. Invited review: Prion-like transmission and spreading of tau pathology. Neuropathology and applied neurobiology 2015, 41, 47–58. [Google Scholar] [CrossRef]
- Braak, H.; Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica 1991, 82, 239–259. [Google Scholar] [CrossRef]
- Vogel, J.W.; Iturria-Medina, Y.; Strandberg, O.T.; Smith, R.; Levitis, E.; Evans, A.C.; Hansson, O. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nature communications 2020, 11, 2612. [Google Scholar] [CrossRef]
- De Calignon, A.; Polydoro, M.; Suárez-Calvet, M.; William, C.; Adamowicz, D.H.; Kopeikina, K.J.; Pitstick, R.; Sahara, N.; Ashe, K.H.; Carlson, G.A.; et al. Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 2012, 73, 685–697. [Google Scholar] [CrossRef]
- Liu, L.; Drouet, V.; Wu, J.W.; Witter, M.P.; Small, S.A.; Clelland, C.; Duff, K. Trans-synaptic spread of tau pathology in vivo. PloS one 2012, 7, e31302. [Google Scholar] [CrossRef]
- Keller, J.M.; Frega, M. Past, present, and future of neuronal models in vitro. In Vitro Neuronal Networks: From Culturing Methods to Neuro-Technological Applications 2019, pp. 3–17.
- Soriano, J. Neuronal Cultures: Exploring Biophysics, Complex Systems, and Medicine in a Dish. Biophysica 2023, 3, 181–202. [Google Scholar] [CrossRef]
- Slanzi, A.; Iannoto, G.; Rossi, B.; Zenaro, E.; Constantin, G. In vitro models of neurodegenerative diseases. Frontiers in cell and developmental biology 2020, 8, 328. [Google Scholar] [CrossRef] [PubMed]
- Calafate, S.; Buist, A.; Miskiewicz, K.; Vijayan, V.; Daneels, G.; De Strooper, B.; de Wit, J.; Verstreken, P.; Moechars, D. Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell reports 2015, 11, 1176–1183. [Google Scholar] [CrossRef]
- Wu, J.W.; Herman, M.; Liu, L.; Simoes, S.; Acker, C.M.; Figueroa, H.; Steinberg, J.I.; Margittai, M.; Kayed, R.; Zurzolo, C.; et al. Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. Journal of Biological Chemistry 2013, 288, 1856–1870. [Google Scholar] [CrossRef] [PubMed]
- Allen, B.; Ingram, E.; Takao, M.; Smith, M.J.; Jakes, R.; Virdee, K.; Yoshida, H.; Holzer, M.; Craxton, M.; Emson, P.C.; et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. Journal of Neuroscience 2002, 22, 9340–9351. [Google Scholar] [CrossRef]
- Soriano, J.; Rodríguez Martínez, M.; Tlusty, T.; Moses, E. Development of input connections in neural cultures. Proceedings of the National Academy of Sciences 2008, 105, 13758–13763. [Google Scholar] [CrossRef]
- Wu, J.W.; Herman, M.; Liu, L.; Simoes, S.; Acker, C.M.; Figueroa, H.; Steinberg, J.I.; Margittai, M.; Kayed, R.; Zurzolo, C.; et al. Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons*. Journal of Biological Chemistry 2013, 288, 1856–1870. [Google Scholar] [CrossRef]
- Puangmalai, N.; Bhatt, N.; Montalbano, M.; Sengupta, U.; Gaikwad, S.; Ventura, F.; McAllen, S.; Ellsworth, A.; Garcia, S.; Kayed, R. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell death & disease 2020, 11, 314. [Google Scholar] [CrossRef]
- Orlandi, J.G.; Fernández-García, S.; Comella-Bolla, A.; Masana, M.; Barriga, G.G.D.; Yaghoubi, M.; Kipp, A.; Canals, J.M.; Colicos, M.A.; Davidsen, J.; et al. NETCAL: an interactive platform for large-scale, NETwork and population dynamics analysis of CALcium imaging recordings. Neuroscience 2017. [Google Scholar]
- Grewe, B.F.; Langer, D.; Kasper, H.; Kampa, B.M.; Helmchen, F. High-speed in vivo calcium imaging reveals neuronal network activity with near-millisecond precision. Nature methods 2010, 7, 399–405. [Google Scholar] [CrossRef]
- Orlandi, J.G.; Soriano, J.; Alvarez-Lacalle, E.; Teller, S.; Casademunt, J. Noise focusing and the emergence of coherent activity in neuronal cultures. Nature Physics 2013, 9, 582–590. [Google Scholar] [CrossRef]
- Montalà-Flaquer, M.; López-León, C.F.; Tornero, D.; Houben, A.M.; Fardet, T.; Monceau, P.; Bottani, S.; Soriano, J. Rich dynamics and functional organization on topographically designed neuronal networks in vitro. iScience 2022, 25, article–105680. [Google Scholar] [CrossRef] [PubMed]
- Ludl, A.A.; Soriano, J. Impact of physical obstacles on the structural and effective connectivity of in silico neuronal circuits. Frontiers in computational neuroscience 2020, 14, 77. [Google Scholar] [CrossRef] [PubMed]
- Stetter, O.; Battaglia, D.; Soriano, J.; Geisel, T. Model-free reconstruction of excitatory neuronal connectivity from calcium imaging signals 2012.
- Tibau, E.; Ludl, A.A.; Ruediger, S.; Orlandi, J.G.; Soriano, J. Neuronal spatial arrangement shapes effective connectivity traits of in vitro cortical networks. IEEE Transactions on Network Science and Engineering 2018, 7, 435–448. [Google Scholar] [CrossRef]
- Rubinov, M.; Sporns, O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010, 52, 1059–1069. [Google Scholar] [CrossRef]
- Latora, V.; Marchiori, M. Economic small-world behavior in weighted networks. The European Physical Journal B-Condensed Matter and Complex Systems 2003, 32, 249–263. [Google Scholar] [CrossRef]
- Blondel, V.D.; Guillaume, J.L.; Lambiotte, R.; Lefebvre, E. Fast unfolding of communities in large networks. Journal of statistical mechanics: theory and experiment 2008, 2008, P10008. [Google Scholar] [CrossRef]
- Holmes, B.B.; Furman, J.L.; Mahan, T.E.; Yamasaki, T.R.; Mirbaha, H.; Eades, W.C.; Belaygorod, L.; Cairns, N.J.; Holtzman, D.M.; Diamond, M.I. Proteopathic tau seeding predicts tauopathy in vivo. Proceedings of the National Academy of sciences 2014, 111, E4376–E4385. [Google Scholar] [CrossRef]
- Jacobi, S.; Soriano, J.; Moses, E. BDNF and NT-3 increase velocity of activity front propagation in unidimensional hippocampal cultures. Journal of neurophysiology 2010, 104, 2932–2939. [Google Scholar] [CrossRef]
- Antonello, P.C.; Varley, T.F.; Beggs, J.; Porcionatto, M.; Sporns, O.; Faber, J. Self-organization of in vitro neuronal assemblies drives to complex network topology. Elife 2022, 11, e74921. [Google Scholar] [CrossRef]
- Frost, B.; Götz, J.; Feany, M.B. Connecting the dots between tau dysfunction and neurodegeneration. Trends in cell biology 2015, 25, 46–53. [Google Scholar] [CrossRef]
- Xu, Q.Q.; Yang, W.; Zhong, M.; Lin, Z.X.; Gray, N.E.; Xian, Y.F. Animal models of Alzheimer’s disease: preclinical insights and challenges. Acta Materia Medica 2023, 2, 192–215. [Google Scholar] [CrossRef]
- Nakai, T.; Yamada, K.; Mizoguchi, H. Alzheimer’s disease animal models: elucidation of biomarkers and therapeutic approaches for cognitive impairment. International journal of molecular sciences 2021, 22, 5549. [Google Scholar] [CrossRef]
- Maruyama, M.; Shimada, H.; Suhara, T.; Shinotoh, H.; Ji, B.; Maeda, J.; Zhang, M.R.; Trojanowski, J.Q.; Lee, V.M.Y.; Ono, M.; et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 2013, 79, 1094–1108. [Google Scholar] [CrossRef] [PubMed]
- Golomb, D.; Ermentrout, G.B. Continuous and lurching traveling pulses in neuronal networks with delay and spatially decaying connectivity. Proceedings of the National Academy of Sciences 1999, 96, 13480–13485. [Google Scholar] [CrossRef] [PubMed]
- Bressloff, P.C. Traveling waves and pulses in a one-dimensional network of excitable integrate-and-fire neurons. Journal of Mathematical Biology 2000, 40, 169–198. [Google Scholar] [CrossRef]
- Feinerman, O.; Segal, M.; Moses, E. Signal propagation along unidimensional neuronal networks. Journal of neurophysiology 2005, 94, 3406–3416. [Google Scholar] [CrossRef]
- Cullen, D.K.; Gilroy, M.E.; Irons, H.R.; LaPlaca, M.C. Synapse-to-neuron ratio is inversely related to neuronal density in mature neuronal cultures. Brain research 2010, 1359, 44–55. [Google Scholar] [CrossRef]
- Hernández-Navarro, L.; Faci-Lázaro, S.; Orlandi, J.G.; Feudel, U.; Gómez-Gardeñes, J.; Soriano, J. Noise-driven amplification mechanisms governing the emergence of coherent extreme events in excitable systems. Physical Review Research 2021, 3, 1–15. [Google Scholar] [CrossRef]
- Delacourte, A.; David, J.P.; Sergeant, N.; Buee, L.; Wattez, A.; Vermersch, P.; Ghozali, F.; Fallet-Bianco, C.; Pasquier, F.; Lebert, F.; et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 1999, 52, 1158–1158. [Google Scholar] [CrossRef]
- Goedert, M. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philosophical transactions of the royal society of london. Series B: biological sciences 1999, 354, 1101–1118. [Google Scholar] [CrossRef]
- Frost, B.; Jacks, R.L.; Diamond, M.I. Propagation of tau misfolding from the outside to the inside of a cell. Journal of biological chemistry 2009, 284, 12845–12852. [Google Scholar] [CrossRef] [PubMed]
- Gómez-Ramos, A.; Díaz-Hernández, M.; Cuadros, R.; Hernández, F.; Avila, J. Extracellular tau is toxic to neuronal cells. FEBS letters 2006, 580, 4842–4850. [Google Scholar] [CrossRef]
- Stancu, I.C.; Vasconcelos, B.; Ris, L.; Wang, P.; Villers, A.; Peeraer, E.; Buist, A.; Terwel, D.; Baatsen, P.; Oyelami, T.; et al. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice. Acta neuropathologica 2015, 129, 875–894. [Google Scholar] [CrossRef] [PubMed]
- Palop, J.J.; Chin, J.; Roberson, E.D.; Wang, J.; Thwin, M.T.; Bien-Ly, N.; Yoo, J.; Ho, K.O.; Yu, G.Q.; Kreitzer, A.; et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 2007, 55, 697–711. [Google Scholar] [CrossRef] [PubMed]
- Maestú, F.; de Haan, W.; Busche, M.A.; DeFelipe, J. Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology. Ageing Research Reviews 2021, 69, 101372. [Google Scholar] [CrossRef]
- Styr, B.; Slutsky, I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease. Nature neuroscience 2018, 21, 463–473. [Google Scholar] [CrossRef]
- Yamada, K.; Holth, J.K.; Liao, F.; Stewart, F.R.; Mahan, T.E.; Jiang, H.; Cirrito, J.R.; Patel, T.K.; Hochgräfe, K.; Mandelkow, E.M.; et al. Neuronal activity regulates extracellular tau in vivo. Journal of Experimental Medicine 2014, 211, 387–393. [Google Scholar] [CrossRef] [PubMed]
- Kobayashi, S.; Tanaka, T.; Soeda, Y.; Takashima, A. Enhanced tau protein translation by hyper-excitation. Frontiers in Aging Neuroscience 2019, 11, 322. [Google Scholar] [CrossRef] [PubMed]
- Dickerson, B.C.; Salat, D.H.; Bates, J.F.; Atiya, M.; Killiany, R.J.; Greve, D.N.; Dale, A.M.; Stern, C.E.; Blacker, D.; Albert, M.S.; et al. Medial temporal lobe function and structure in mild cognitive impairment. Annals of neurology 2004, 56, 27–35. [Google Scholar] [CrossRef]
- Targa Dias Anastacio, H.; Matosin, N.; Ooi, L. Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? Translational Psychiatry 2022, 12, 257. [Google Scholar] [CrossRef]
- Lee, H.g.; Perry, G.; Moreira, P.I.; Garrett, M.R.; Liu, Q.; Zhu, X.; Takeda, A.; Nunomura, A.; Smith, M.A. Tau phosphorylation in Alzheimer’s disease: pathogen or protector? Trends in molecular medicine 2005, 11, 164–169. [Google Scholar] [CrossRef]
- Alavi Naini, S.M.; Soussi-Yanicostas, N.; et al. Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies? Oxidative medicine and cellular longevity 2015, 2015. [Google Scholar] [CrossRef]
- Cassidy, L.; Fernandez, F.; Johnson, J.B.; Naiker, M.; Owoola, A.G.; Broszczak, D.A. Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics. Complementary therapies in medicine 2020, 49, 102294. [Google Scholar] [CrossRef] [PubMed]
- Hanger, D.P.; Anderton, B.H.; Noble, W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends in molecular medicine 2009, 15, 112–119. [Google Scholar] [CrossRef]
- Castellani, R.J.; Nunomura, A.; Lee, H.g.; Perry, G.; Smith, M.A. Phosphorylated tau: toxic, protective, or none of the above. Journal of Alzheimer’s Disease 2008, 14, 377–383. [Google Scholar] [CrossRef] [PubMed]
- Cárdenas-Aguayo, M.d.C.; Gómez-Virgilio, L.; DeRosa, S.; Meraz-Ríos, M.A. The role of tau oligomers in the onset of Alzheimer’s disease neuropathology. ACS chemical neuroscience 2014, 5, 1178–1191. [Google Scholar] [CrossRef] [PubMed]
- Palop, J.J.; Chin, J.; Mucke, L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443, 768–773. [Google Scholar] [CrossRef]
- Turrigiano, G. Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. Cold Spring Harbor perspectives in biology 2012, 4, a005736. [Google Scholar] [CrossRef]
- Desai, N.S.; Rutherford, L.C.; Turrigiano, G.G. Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nature neuroscience 1999, 2, 515–520. [Google Scholar] [CrossRef]
- Fauth, M.; Wörgötter, F.; Tetzlaff, C. The formation of multi-synaptic connections by the interaction of synaptic and structural plasticity and their functional consequences. PLoS computational biology 2015, 11, e1004031. [Google Scholar] [CrossRef] [PubMed]












Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).